---
$id: https://graph.org.ai/products/commodity/51131663
$type: Product
source: UNSPSC
code: "51131663"
title: "Dabigatran etexilate"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dabigatran etexilate

**UNSPSC Code**: 51131663
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2E18WX195X. European Medicines Agency schedules Dabigatran etexilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20521. Dabigatran etexilate generally arises in the molecular formula C34H41N7O5. The term DABIGATRAN ETEXILATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule dabigatran etexilate under HS 29333999 and SITC 51574. As of Q4 2014, DABIGATRAN ETEXILATE remains the US FDA Preferred Term for this commodity. Dabigatran etexilate bears US NLM identifiers UMLS ID C1571583 and NCI Concept Code C87480. SMILES: CCCCCCOC(=O)/N=C(\C1CCC(CC1)NCC2NC3CC(CCC3N2C)C(=O)N(CCC(=O)OCC)C4CCCCN4)/N.

